Not recruiting
Breast cancer
Not recruitingRegistered drugNo placebo
Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
Registered drugNo placebo
- Disease:Breast cancer
- Substances:Fulvestrant(3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Fulvestrant
